136
Participants
Start Date
August 31, 2005
Study Completion Date
December 31, 2005
PROVIGIL 200 mg
PROVIGIL 200 mg/day
Armodafinil 250 mg
Armodafinil 250 mg/day
Armodafinil 200 mg
Armodafinil 200 mg/day
Armodafinil 150 mg
Armodafinil 150 mg/day
Placebo
Matching placebo tablets
Clinilabs / Sleep Disorders In, New York
Consolidated Clinical Trials, Pittsburgh
Center for Sleep/Wake Disorder, Chevy Chase
Wake Research Associates, Raleigh
SleepMed of South Carolina, Columbia
Neurotrials Research, Atlanta
SLEEPMED, Inc., Macon
St. Vincent Mercy Medical Cent, Toledo
Henry Lahmeyer, MD, Northfield
Vince and Associates Clinical, Overland Park
Central Arkansas Research, Hot Springs
Radiant Research Salt Lake, Salt Lake City
Psypharma Clinical Research, Phoenix
PsyPharma Clinical Tucson, Tucson
Clinical Rsch Center of Nevada, Las Vegas
Pacific Sleep Medicine Service, Los Angeles
Pacific Sleep Medicine Service, San Diego
BMR HealthQuest, San Diego
Stanford University, Stanford
Brigham and Women's Hospital, Boston
Lead Sponsor
Cephalon
INDUSTRY